STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
104
13F, latest reported quarter
What the filings say about TRS
Insiders, 180 days
-$876.9K net sold
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Trimas insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, TRIMAS CORP insiders sold a net $876.9K of stock across 78 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
7 earlier Form 4 trades (code P or S) here by this insider (7 buys), the last on Feb 28, 2025.
-7.2% median (-3.0% mean) 90-day return after 7 previous buys.
The trade is 26.0% of the 57,762 shares held after it.
No other insider sold within 30 days.
104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Parker Herbert K sold about $675.5K of TRS on Jun 30, 2026, the largest insider sale at the company since 2021; 104 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 8.3% of the 36,191 shares held after it.
No other insider sold within 30 days.
104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: General Counsel and Secretary Robin Jodi F. sold about $123.3K of TRS on May 5, 2026, the largest insider sale at the company since 2023; 104 funds added in the latest 13F quarter.
78 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
TRS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Parker Herbert K
Filed 2026-06-30
$675.5K
TRS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Lord Abbett Focused Small Cap Value Fund
$2.8M position · as of 2026-07-31
2.9%
Small-Cap Value Series
$8.7M position · as of 2026-05-31
2.2%
Brighthouse Small Cap Value Portfolio
$15.3M position · as of 2026-06-30
2.1%
Allspring Special Small Cap Value Fund
$61.4M position · as of 2026-06-30
2.1%
Lazard US Small Cap Equity Select Portfolio
$660.1K position · as of 2026-06-30
1.7%
Loomis Sayles Small Cap Value Fund
$4.1M position · as of 2026-06-30
1.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Thomas Amato
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$4.0M
$1.5M
$853.7K
-18%
+68%
2022
$4.4M
$1.3M
$1.1M
-11%
+28%
2021
$4.6M
$4.9M
$1.6M
+18%
+41%
2020
$4.6M
$4.5M
$1.6M
+1%
+12%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $876.9K sold by insiders over 180 days, 104 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM TRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
$893.5M
FY Dec 2022
$883.8M
FY Dec 2021
$857.1M
Jun 2026
$174.6M
Mar 2026
$168.3M
Dec 2025
$155.5M
Sep 2025
$269.3M
Jun 2025
$274.8M
Mar 2025
$241.7M
Dec 2024
$149.7M
Sep 2024
$229.4M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM TRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
+4.5%
FY Dec 2022
+7.5%
FY Dec 2021
+6.7%
Jun 2026
+7.7%
Mar 2026
+475.9%
Dec 2025
+52.5%
Sep 2025
+3.5%
Jun 2025
+6.1%
Mar 2025
+5.1%
Dec 2024
+3.8%
Sep 2024
+1.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM TRS
FY Dec 2025
n/a
FY Dec 2024
$12.8M
FY Dec 2023
$34.0M
FY Dec 2022
$26.6M
FY Dec 2021
$89.2M
Jun 2026
-$45.0M
Mar 2026
-$24.6M
Dec 2025
$36.8M
Sep 2025
$22.8M
Jun 2025
$18.1M
Mar 2025
-$3.8M
Dec 2024
$12.1M
Sep 2024
$10.2M
At each fiscal year end
Single quarter
Debt to equity
0.28x
long-term 2026-06-30 plus current 2024-09-30 (21 months older than the period end); equity 2026-06-30
Debt to equity TRS
FY Dec 2025
0.67x
FY Dec 2024
0.60x
FY Dec 2023
0.59x
FY Dec 2022
1.07x
FY Dec 2021
1.11x
Jun 2026
0.28x
Mar 2026
0.27x
Dec 2025
0.67x
Sep 2025
0.56x
Jun 2025
0.59x
Mar 2025
0.63x
Dec 2024
0.60x
Sep 2024
0.60x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.05x
TTM operating cash flow over long-term 2026-06-30 plus current 2024-09-30 (21 months older than the period end)
Cash flow to debt TRS
FY Dec 2025
0.25x
FY Dec 2024
0.16x
FY Dec 2023
0.22x
FY Dec 2022
0.10x
FY Dec 2021
0.19x
Jun 2026
0.05x
Mar 2026
0.22x
Dec 2025
0.25x
Sep 2025
0.25x
Jun 2025
0.21x
Mar 2025
0.18x
Dec 2024
0.16x
Sep 2024
0.16x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+83.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity TRS
FY Dec 2025
+17.5%
FY Dec 2024
+3.6%
FY Dec 2023
+6.0%
FY Dec 2022
+10.3%
FY Dec 2021
+9.4%
Jun 2026
+83.9%
Mar 2026
+85.1%
Dec 2025
+17.5%
Sep 2025
+6.3%
Jun 2025
+5.4%
Mar 2025
+4.6%
Dec 2024
+3.6%
Sep 2024
+3.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+49.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets TRS
FY Dec 2025
+8.6%
FY Dec 2024
+1.8%
FY Dec 2023
+3.0%
FY Dec 2022
+5.1%
FY Dec 2021
+4.6%
Jun 2026
+49.0%
Mar 2026
+49.2%
Dec 2025
+8.6%
Sep 2025
+3.1%
Jun 2025
+2.7%
Mar 2025
+2.3%
Dec 2024
+1.8%
Sep 2024
+2.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital TRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
+4.2%
FY Dec 2022
+6.2%
FY Dec 2021
+6.6%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+3.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed TRS
FY Dec 2025
n/a
FY Dec 2024
+1.3%
FY Dec 2023
+4.3%
FY Dec 2022
+8.6%
FY Dec 2021
+8.6%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+0.6%
Jun 2025
-0.0%
Mar 2025
+0.8%
Dec 2024
+1.3%
Sep 2024
+3.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
1.64x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing TRS
FY Dec 2025
11.94x
FY Dec 2024
40.98x
FY Dec 2023
26.11x
FY Dec 2022
17.67x
FY Dec 2021
28.24x
Jun 2026
1.87x
Mar 2026
1.49x
Dec 2025
11.94x
Sep 2025
35.78x
Jun 2025
31.44x
Mar 2025
30.43x
Dec 2024
40.98x
Sep 2024
39.28x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$571.9M
market value at close 2026-10-27 on 2026-07-23 shares, plus long-term 2026-06-30 plus current 2024-09-30 (21 months older than the period end), minus cash 2026-06-30
Enterprise value TRS
FY Dec 2025
$1.9B
FY Dec 2024
$1.4B
FY Dec 2023
$1.4B
FY Dec 2022
$1.8B
FY Dec 2021
$2.1B
Jun 2026
$767.8M
Mar 2026
$440.3M
Dec 2025
$1.9B
Sep 2025
$1.9B
Jun 2025
$1.6B
Mar 2025
$1.4B
Dec 2024
$1.4B
Sep 2024
$1.4B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield TRS
FY Dec 2025
n/a
FY Dec 2024
+1.3%
FY Dec 2023
+3.2%
FY Dec 2022
+2.3%
FY Dec 2021
+5.6%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+3.1%
Jun 2025
+3.2%
Mar 2025
+2.7%
Dec 2024
+1.3%
Sep 2024
+1.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.00x
P/E over trailing EPS growth of 2541%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing TRS
FY Dec 2025
0.03x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.89x
FY Dec 2021
n/a
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.03x
Sep 2025
0.54x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
TRS ranks highest on profitability (99th percentile) and insider conviction (58th), and lowest on risk and compliance (16th), among Industrials peers.
Profitability
99
Inputs
Return on equity+83.9% · 97 pct, sector of 198
Return on assets+49.0% · 100 pct, sector of 224
Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
43
Inputs
Debt to equity0.28x · 63 pct, sector of 214
Cash flow to debt0.05x · 24 pct, sector of 173
Growth
38
Inputs
Revenue growth, YoY+2.4% · 38 pct, sector of 254
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
58
Inputs
Net Form 4 buying (codes P and S), 180d-$877K · 54 pct, sector of 170
Insider buyers, 180d1 · 63 pct, sector of 172
Institutional and government
40
Inputs
Funds adding, latest quarter104 · 40 pct, sector of 201
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
16
Inputs
Short interest, % of float+12.6% · 13 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y1.55 per $1B · 0 pct, sector of 191
New text in Risk Factors, latest 10-K+15.6% · 35 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
TRS filings, in plain words
Are Trimas insiders buying or selling TRS?
In the 180 days to 2026-10-28, Trimas insiders were net sellers, a net $876.9K: $5.0K of purchases and $882.0K of sales reported on Form 4, by 1 buyer and 2 sellers.
Read the full summary
In the 180 days to 2026-10-28, Trimas insiders were net sellers of TRS, a net $876.9K across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Sales outweighed purchases more than tenfold by value. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.